1.ТЭМБҮҮ ӨВЧНИЙ ӨВЧЛӨЛИЙН ТАРХАЛТЫН ӨНӨӨГИЙН БАЙДАЛ, ТУЛГАМДАЖ БУЙ АСУУДАЛ
Innovation 2017;11(2):12-12
BACKGROUND. Statewide STIs does not decrease adamantly in last years, especially syphilis
rate is amalgamative. Public health precaution cogency-based, assess prevalence of HIV/STI is
supposed to encourage and organize intentionally.
PURPOSE: assess prevalence of STIs2 among total persons of SBD. METHOD: analysis data based
on outpatient department examination intelligences of patients examined in SBD clinic STI department
from 2013 to 2016, controlling form and infectious disease activity EMT-304 reports. RESULT:
12.84% of total infectious disease registered in SBD from 2013-2016 is STI. 63% of the total STIs
is syphilis. The causes of 68.05 females, 31.95% males of STIs total patients are that the females
included more in a preventative inspection and pregnant inspections. Secondary and latent
syphilis increasing regularly in every year and decreasing primary syphilis show the high prevalence
of syphilis among SBD persons. Gonorrhea and trichomoniasisincreased by 1 promil on
10000 persons in every year. CONCLUSION: SBD STIs does not decrease constantly in last 4 years.
Detection of STIs among pregnant improved by implementing ‘on point service’. High rate STI of
among young persons caused insufficient information and knowledge about STIs and unhabit
preventative of STIs.
2.Phase III multi-centre open-label randomized controlled trial of selective internal radiation therapy (SIRT) versus Sorafenib in locally advanced hepatocellular carcinoma(SIRveNIB)
Ariunaa Kh ; Sanduijav R ; Bolormaa Ya ; Tuyatsetseg A
Mongolian Medical Sciences 2016;177(3):20-24
Background
This study is a multi-centre, open-label, randomised controlled trial that will compare the impact of
selective internal radiation therapy (SIRT) using SIR-Spheres® yttrium-90 microspheres versus sorafenib
on overall survival in patients with locally advanced hepatocellular carcinoma (HCC). A definitive RCT
comparing the 2 most promising therapies in locally-advanced HCC will impact on outcomes in a large
number of patients and change clinical practice. This will also pave the way for future trials in combined
modality therapies in HCC.
Methods
The study is structured so that patients with locally advanced HCC, who satisfy the study eligibility
criteria, will be randomised to receive either: Treatment Arm A: Oral Sorafenib therapy at a dose of 400
mg b.i.d until disease progression, no further response, complete regression or unacceptable toxicity or
Treatment Arm B: A single administration of SIR-Spheres into the liver targeted at HCC in the liver by
the trans-arterial route.
Results
Twenty patients treated with 90Y-RE and nineteen patients received Sorafenib at our institution from 14
March 2011, and 30 June 2016 were included. Data from 39 consecutive patients were analyzed. The
majority of patients were Child Pugh class B(90%), Barcelona Clinic liver Cancer(BCLC) stage C(58.5%)
and Okuda class I (89.5%). Approximately 71% patients diagnosed in IIIa stage and 70% of patients had
HBV infection. In the analysis for best response, three of 20 patients in the SIRT group (15%) achieved
a partial response 7 of 19 patients (46%) had stable disease, whereas in Sorafenib group, two of 19
patients in the SIRT group (12%) achieved a partial response 9 of 19 patients (39%) had stable disease.
Conclusion
This study shows the potential efficacy of SIR-Spheres and sorafenib. In summary, selective internal
radiation therapy (SIRT) using SIR-Spheres is a promising treatment for well selected patients with
unresectable HCC. Sorafenib is effective for the patients with locally advanced HCC without portal vein
thrombosis (PVT).
3.A case of moya-moya syndrome in mongolia
Baasanjav D ; Ariunaa J ; Oyun B ; Boldbat R ; Khandsuren B ; Byambasuren TS ; Amarjargal G
Mongolian Medical Sciences 2010;153(3):78-81
In this published case of a male patient B., 53, has some epidemiological specifics. There is transient ischemic attack (TIA) syndrome, particularly while with clear mind there is sudden temporary paralysis of left leg and arm and loss of ability to speak. Temporary refers here to a period of 2-3 minutes after which everything gets back to normal. The incidence occurred again in two days during the medical treatment.MRA test concluded on the presence of obvious stenosis at the beginning part of both sides of a.cerebri media. The mentioned blood vessel pictures were undefined. Hence selected catheter angiography has been done with a purpose to establish the presence of a full occlusion or clogging stenosis in a.cerebri media and to clarify which specific vessels are being mobilized for the collateral supply. This test established that the a.cerebri media had full occlusion on both sides.A duplex sonography conducted in order to clarify characteristics of the clogging (blocking) process concluded the presence of gradual thickening of and blocking in intima (inner wall) of a. carotis interna. Based on these tests we considered that despite the atherosclerosis symptoms (Ischemia in ECG, 20 years of smoking,being male and aged 53, etc), this case had conditions of gradual (slow progressing) arteriopathy. Thus because of the presence in this case simultaneous arteriopathy process (gradually progressing and causing the blocking) in addition to atherosclerosis syndromes we consider it as a Moya-Moya syndrome. The disease of Moya-Moya is mostly found in children and youth and is a unique arteriopathy considered unrelated with atherosclerosis.